Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas B Brunner

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 12, 2008
Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boostThomas B Brunner, Andreas Rupp, Winfrid Melzner, et al.
Seminars in Radiation Oncology|March 6, 2012
Cancer stem cells as a predictive factor in radiotherapyThomas B Brunner, Leoni A Kunz-Schughart, Philipp Grosse-Gehling, et al.
Acta Oncologica (Stockholm, Sweden)|August 21, 2013
Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancerSamantha Warren, Mike Partridge, Emmanouil Fokas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2026
Reply to: Quality of Chemoradiotherapy in Esophageal Adenocarcinoma MattersThomas B Brunner, Simon Kirste, Claudia Schmoor, et al.
Cancer Research|May 12, 2011
Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signalingTine S Mantoni, Serena Lunardi, Osama Al-Assar, et al.
Journal of Cancer Research and Clinical Oncology|October 16, 2022
Can alternative liver function scores facilitate the establishment of an indication for radioablative therapy in patients with hepatocellular carcinoma?Dominik Ott, Ahmed Gawish, Anke Lux, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2008
Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definitionIris Meier, Susanne Merkel, Thomas Papadopoulos, et al.
BMC Cancer|March 7, 2007
Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO)Thomas B Brunner, Gerhard G Grabenbauer, Thomas Meyer, et al.
Cancer Biology & Therapy|May 12, 2011
Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G2 fractionOsama Al-Assar, Tine Mantoni, Serena Lunardi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 12, 2022
Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancerAhmed Gawish, Nurlan Abdullayev, Souhir El-Arayedh, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 12, 2008
Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boostThomas B Brunner, Andreas Rupp, Winfrid Melzner, et al.
Seminars in Radiation Oncology|March 6, 2012
Cancer stem cells as a predictive factor in radiotherapyThomas B Brunner, Leoni A Kunz-Schughart, Philipp Grosse-Gehling, et al.
Acta Oncologica (Stockholm, Sweden)|August 21, 2013
Comparing dose-volume histogram and radiobiological endpoints for ranking intensity-modulated arc therapy and 3D-radiotherapy treatment plans for locally-advanced pancreatic cancerSamantha Warren, Mike Partridge, Emmanouil Fokas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2026
Reply to: Quality of Chemoradiotherapy in Esophageal Adenocarcinoma MattersThomas B Brunner, Simon Kirste, Claudia Schmoor, et al.
Cancer Research|May 12, 2011
Pancreatic stellate cells radioprotect pancreatic cancer cells through β1-integrin signalingTine S Mantoni, Serena Lunardi, Osama Al-Assar, et al.
Journal of Cancer Research and Clinical Oncology|October 16, 2022
Can alternative liver function scores facilitate the establishment of an indication for radioablative therapy in patients with hepatocellular carcinoma?Dominik Ott, Ahmed Gawish, Anke Lux, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 2008
Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definitionIris Meier, Susanne Merkel, Thomas Papadopoulos, et al.
BMC Cancer|March 7, 2007
Primary resection versus neoadjuvant chemoradiation followed by resection for locally resectable or potentially resectable pancreatic carcinoma without distant metastasis. A multi-centre prospectively randomised phase II-study of the Interdisciplinary Working Group Gastrointestinal Tumours (AIO, ARO, and CAO)Thomas B Brunner, Gerhard G Grabenbauer, Thomas Meyer, et al.
Cancer Biology & Therapy|May 12, 2011
Breast cancer stem-like cells show dominant homologous recombination due to a larger S-G2 fractionOsama Al-Assar, Tine Mantoni, Serena Lunardi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 12, 2022
Metabolic response after 68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases prostate cancerAhmed Gawish, Nurlan Abdullayev, Souhir El-Arayedh, et al.
Pageof 10